Clinical Trial Update: A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating long-term lacosamide monotherapy in epilepsy patients who completed prior study SP0994.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2021-01-22